Cheng Jen-Hao, Hung Chi-Feng, Yang Shyh-Chyun, Wang Jih-Pyang, Won Shen-Jeu, Lin Chun-Nan
School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Bioorg Med Chem. 2008 Aug 1;16(15):7270-6. doi: 10.1016/j.bmc.2008.06.031. Epub 2008 Jun 21.
In an effort to develop novel anti-tumor, or cancer chemopreventive agents, a series of 2',5'-dialkoxylchalcones were prepared by Claisen-Schmidt condensation of appropriate acetophenones with suitable aromatic aldehyde. In vitro screening revealed low micromolar activity (IC(50)) against several human cancer cell lines. Selective compound 10 induced an accumulation of A549 cells in the G(2)/M phase arrest which was well correlated with inhibitory activity against tubulin polymerization. Cytotoxic compounds 3 and 12 showed significant inhibitory effects on NO production in lipopolysaccharide (LPS)-activated RAW 264.7 macrophage-like cells while cytotoxic compound 10 revealed potent inhibitory effect on TNF-alpha formation in RAW 264.7 cells in response to LPS. Compounds 3 and 10 also showed significant inhibitory effects on xanthine oxidase. The present results suggested that compounds 3 and 10 were potential to be served as cancer chemopreventive agents.
为了开发新型抗肿瘤或癌症化学预防剂,通过适当的苯乙酮与合适的芳香醛的克莱森-施密特缩合反应制备了一系列2',5'-二烷氧基查耳酮。体外筛选显示对几种人类癌细胞系具有低微摩尔活性(IC(50))。选择性化合物10诱导A549细胞在G(2)/M期停滞积累,这与对微管蛋白聚合的抑制活性密切相关。细胞毒性化合物3和12对脂多糖(LPS)激活的RAW 264.7巨噬细胞样细胞中的NO产生具有显著抑制作用,而细胞毒性化合物10对RAW 264.7细胞中响应LPS的TNF-α形成具有强效抑制作用。化合物3和10对黄嘌呤氧化酶也显示出显著抑制作用。目前的结果表明化合物3和10有潜力用作癌症化学预防剂。